Richard G. Stock

12.7k total citations · 2 hit papers
252 papers, 8.7k citations indexed

About

Richard G. Stock is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Rheumatology. According to data from OpenAlex, Richard G. Stock has authored 252 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 218 papers in Pulmonary and Respiratory Medicine, 71 papers in Radiation and 31 papers in Rheumatology. Recurrent topics in Richard G. Stock's work include Prostate Cancer Diagnosis and Treatment (192 papers), Prostate Cancer Treatment and Research (155 papers) and Advanced Radiotherapy Techniques (71 papers). Richard G. Stock is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (192 papers), Prostate Cancer Treatment and Research (155 papers) and Advanced Radiotherapy Techniques (71 papers). Richard G. Stock collaborates with scholars based in United States, Canada and Greece. Richard G. Stock's co-authors include Nelson N. Stone, Jamie A. Cesaretti, J. Keith DeWyngaert, Christopher Iannuzzi, Barry S. Rosenstein, Pamela D. Unger, Johnny Kao, Michael J. Zeléfsky, Pam Unger and Marisa Kollmeier and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Richard G. Stock

246 papers receiving 8.4k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Dose–Response Study for I-125 Prostate Implants

1998 445 citations Richard G. Stock, Nelson N. Stone et al. International Journal of Radiation Oncology*Biology*Physics profile →
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy

2012 329 citations Richard G. Stock, Nelson N. Stone et al. Brachytherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard G. Stock United States	53	6.7k	3.5k	1.3k	1.2k	986	252	8.7k
Kent E. Wallner United States	53	7.4k 1.1×	3.5k 1.0×	1.6k 1.2×	1.3k 1.0×	1.3k 1.3×	301	9.6k
Nelson N. Stone United States	53	6.5k 1.0×	2.9k 0.8×	1.3k 1.0×	930 0.8×	1.2k 1.3×	240	8.2k
Juanita Crook Canada	51	5.6k 0.8×	3.1k 0.9×	1.9k 1.5×	1.5k 1.2×	665 0.7×	278	8.3k
Irving Kaplan United States	35	4.3k 0.6×	1.3k 0.4×	1.0k 0.8×	748 0.6×	434 0.4×	109	5.5k
Thomas M. Pisansky United States	51	7.2k 1.1×	2.8k 0.8×	2.3k 1.8×	1.3k 1.1×	246 0.2×	215	9.8k
Sucha O. Asbell United States	43	7.9k 1.2×	2.0k 0.6×	3.0k 2.3×	1.2k 0.9×	250 0.3×	120	10.1k
Gillian Duchesne Australia	36	3.1k 0.5×	1.7k 0.5×	1.2k 0.9×	1.1k 0.9×	217 0.2×	159	4.8k
Richard K. Valicenti United States	36	4.6k 0.7×	2.3k 0.7×	898 0.7×	1.0k 0.8×	132 0.1×	133	5.6k
John C. Blasko United States	38	4.1k 0.6×	2.4k 0.7×	843 0.6×	699 0.6×	514 0.5×	101	5.3k
Mark K. Buyyounouski United States	38	4.0k 0.6×	2.2k 0.6×	581 0.4×	1.2k 1.0×	165 0.2×	174	5.0k

Countries citing papers authored by Richard G. Stock

Since Specialization

Citations

This map shows the geographic impact of Richard G. Stock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard G. Stock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard G. Stock more than expected).

Fields of papers citing papers by Richard G. Stock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard G. Stock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard G. Stock. The network helps show where Richard G. Stock may publish in the future.

Co-authorship network of co-authors of Richard G. Stock

This figure shows the co-authorship network connecting the top 25 collaborators of Richard G. Stock. A scholar is included among the top collaborators of Richard G. Stock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard G. Stock. Richard G. Stock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Joyce, Kieran, et al.. (2021). Live implant dosimetry may be an effective replacement for postimplant computed tomography in localized prostate cancer patients receiving low dose rate brachytherapy. Brachytherapy. 20(4). 873–882. 1 indexed citations

Kerns, Sarah L., Michael A. Diefenbach, Raymond A. Koski, et al.. (2020). Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. Advances in Radiation Oncology. 5(5). 897–904. 1 indexed citations

Sagalovich, Daniel, Michael Leapman, John P. Sfakianos, et al.. (2016). The impact of timing of salvage hormonal therapy on survival after brachytherapy for prostate cancer. Brachytherapy. 15(6). 730–735. 3 indexed citations

Stock, Richard G., et al.. (2012). Long‐term potency preservation following brachytherapy for prostate cancer. British Journal of Urology. 110(2). 221–225. 26 indexed citations

Stone, Nelson N., et al.. (2011). Factors Influencing Urinary Symptoms 10 Years After Permanent Prostate Seed Implantation. The Journal of Urology. 187(1). 117–123. 25 indexed citations

Forsythe, Kevin, Ryan J. Burri, Nelson N. Stone, & Richard G. Stock. (2011). Predictors of Metastatic Disease After Prostate Brachytherapy. International Journal of Radiation Oncology*Biology*Physics. 83(2). 645–652. 9 indexed citations

Cesaretti, Jamie A., et al.. (2007). Brachytherapy for the Treatment of Prostate Cancer. The Cancer Journal. 13(5). 302–312. 38 indexed citations

Rosenstein, Barry S., Jamie A. Cesaretti, Richard G. Stock, et al.. (2007). A Validation Study to Examine the Correlation Between Possession of Variants in the ATM Gene With the Development of Erectile Dysfunction in Prostate Cancer Patients Treated With Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 69(3). S29–S29. 3 indexed citations

Peters, Christopher A., Jamie A. Cesaretti, Nelson N. Stone, & Richard G. Stock. (2006). Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease. International Journal of Radiation Oncology*Biology*Physics. 66(2). 424–429. 37 indexed citations

10.

Ho, Alice Y., David P. Atencio, Sheila Annie Peters, et al.. (2006). Genetic Predictors of Adverse Radiotherapy Effects: The Gene-PARE project. International Journal of Radiation Oncology*Biology*Physics. 65(3). 646–655. 78 indexed citations

11.

Stock, Richard G., Nelson N. Stone, Jamie A. Cesaretti, & Barry S. Rosenstein. (2005). Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results. International Journal of Radiation Oncology*Biology*Physics. 64(2). 527–533. 196 indexed citations

12.

Andreassen, Christian Nicolaj, Jens Overgaard, Jan Alsner, et al.. (2005). ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 64(3). 776–783. 76 indexed citations

13.

Cesaretti, Jamie A., Richard G. Stock, Steven Lehrer, et al.. (2004). ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 61(1). 196–202. 75 indexed citations

14.

Stone, Nelson N., et al.. (2003). Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Brachytherapy. 2(1). 17–25. 59 indexed citations

15.

Stone, Nelson N. & Richard G. Stock. (2003). Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy. Brachytherapy. 2(1). 32–39. 15 indexed citations

16.

Stock, Richard G.. (2002). Importance of Post-Implant Dosimetry in Permanent Prostate Brachytherapy. European Urology. 41(4). 434–439. 66 indexed citations

17.

Lehrer, Steven, et al.. (2001). Increased serum insulin associated with increased risk of prostate cancer recurrence. The Prostate. 50(1). 1–3. 63 indexed citations

18.

Stock, Richard G., Johnny Kao, & Nelson N. Stone. (2001). PENILE ERECTILE FUNCTION AFTER PERMANENT RADIOACTIVE SEED IMPLANTATION FOR TREATMENT OF PROSTATE CANCER. The Journal of Urology. 165(2). 436–439. 147 indexed citations

19.

Stock, Richard G., et al.. (2000). The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy. Cancer. 89(8). 1829–1834. 39 indexed citations

20.

Stock, Richard G., et al.. (1995). A 30-Year Experience in the Management of Primary Carcinoma of the Vagina: Analysis of Prognostic Factors and Treatment Modalities. Gynecologic Oncology. 56(1). 45–52. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact